1602 / 1708
[29] Merchant TE, Haida T, Wang MH, Finlay JL, Leibel SA.
Anaplastic ependymoma: treatment of pediatric patients with
or without craniospinal radiation therapy. J Neurosurg 1997;86:
943–9.
[30] Merchant TE, Mulhern RK, Krasin MJ, et al. Preliminary results
froma phase II trial of conformal radiation therapy and evaluation
of radiation-related CNS effects for pediatric patients with
localized ependymoma. J Clin Oncol 2004;22:3156–62.
[31] Mork SJ, Loken AC. Ependymoma: a follow-up study of 101
cases. Cancer 1977;40:907–15.
[32] Mulhern RK, Hancock J, Fairclough D, Kun L. Neuropsycholo-
gical status of children treated for brain tumors: a critical
review and integrative analysis. Med Pediatr Oncol 1992;20:
181–91.
[33] Nazar GB, Hoffman HJ, Becker LE, Jenkin D, Humphreys RP,
Hendrick EB. Infratentorial ependymomas in childhood: prog-
nostic factors and treatment. J Neurosurg 1990;72:408–17.
[34] Oya N, Shibamoto Y, Nagata Y, Negoro Y, Hiraoka M. Post-
operative radiotherapy for intracranial ependymoma: analysis
of prognostic factors and patterns of failure. J Neurooncol
2002;56:87–94.
[35] Palma L, Celli P, Mariottini A, Zalaffi A, Schettini G. The
importance of surgery in supratentorial ependymomas. Long-
term survival in a series of 23 cases. Childs Nerv Syst 2000;16:
170–5.
[36] Paulino AC, Wen BC, Buatti JM, et al. Intracranial ependymo-
mas: an analysis of prognostic factors and patterns of failure.
Am J Clin Oncol 2002;25:117–22.
[37] Pollack IF. Brain tumors in children. N Engl J Med 1994;331:
1500–7.
[38] Pollack IF, Gerszten PC, Martinez AJ, et al. Intracranial
ependymomas of childhood: long-term outcome and prognostic
factors. Neurosurgery 1995;37:655–66 [discussion 666–657].
[39] Robertson PL, Zeltzer PM, Boyett JM, et al. Survival and
prognostic factors following radiation therapy and chemother-
apy for ependymomas in children: a report of the Children’s
Cancer Group. J Neurosurg 1998;88:695–703.
[40] Rousseau P, Habrand JL, Sarrazin D, et al. Treatment of
intracranial ependymomas of children: review of a 15-year
experience. Int J Radiat Oncol Biol Phys 1994;28:381–6.
[41] Shaw EG, Evans RG, Scheithauer BW, Ilstrup DM, Earle JD.
Postoperative radiotherapy of intracranial ependymoma in
pediatric and adult patients. Int J Radiat Oncol Biol Phys 1987;
13:1457–62.
[42] Silber JH, Radcliffe J, Peckham V, et al. Whole-brain
irradiation and decline in intelligence: the influence of dose
and age on IQ score. J Clin Oncol 1992;10:1390–6.
[43] Suc E, Kalifa C, Brauner R, et al. Brain tumours under the age of
three. The price of survival. A retrospective study of 20 long-
term survivors. Acta Neurochir (Wien) 1990;106:93–8.
[44] Timmermann B, Kortmann RD, Kuhl J, et al. Combined
postoperative irradiation and chemotherapy for anaplastic
ependymomas in childhood: results of the German prospective
trials HIT 88/89 and HIT 91. Int J Radiat Oncol Biol Phys 2000;
46:287–95.
[45] Tomita T, McLone DG. Brain tumors during the first twenty-four
months of life. Neurosurgery 1985;17:913–9.
[46] van Eys J, Cangir A, Coody D, Smith B. MOPP regimen as primary
chemotherapy for brain tumors in infants. J Neurooncol 1985;3:
237–43.
[47] van Veelen-Vincent ML, Pierre-Kahn A, Kalifa C, et al.
Ependymoma in childhood: prognostic factors, extent of
surgery, and adjuvant therapy. J Neurosurg 2002;97:827–35.
[48] Wallner KE, Wara WM, Sheline GE, Davis RL. Intracranial
ependymomas: results of treatment with partial or whole brain
irradiation without spinal irradiation. Int J Radiat Oncol Biol
Phys 1986;12:1937–41.
[49] White L, Kellie S, Gray E, et al. Postoperative chemotherapy in
children less than 4 years of age with malignant brain tumors:
promising initial response to a VETOPEC-based regimen. A
Study of the Australian and New Zealand Children’s Cancer
Study Group (ANZCCSG). J Pediatr Hematol Oncol 1998;20:
125–30.
B. Timmermann et al. / Radiotherapy and Oncology 77 (2005) 278–285
285